Table of Contents  
ORIGINAL PAPER
Year : 2011  |  Volume : 2  |  Issue : 1  |  Page : 21-25  

Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study


1 Department of Pharmacology, Government Medical College, Bhavnagar, India
2 Department of Pharmacology, Shri Meghji Pethraji Shah Medical College, Jamnagar, India
3 College of Dental Science and Research Institute, Ahmedabad, Gujarat, India

Date of Web Publication25-Feb-2011

Correspondence Address:
Mukeshkumar B Vora
Department of Pharmacology, Government Medical College, Bhavnagar 364 001, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-500X.77102

Rights and Permissions
   Abstract 

Objective: To find out incidence of adverse drug reactions (ADR) in patients of internal medicine wards and study various aspects of ADR, e.g., causality, mortality, drugs commonly causing ADR in internal medicine wards of Guru Gobind Singh Hospital, Jamnagar, a tertiary care hospital. Materials and Methods: This was prospective, observational study carried out at Department of Medicine, Shri Meghji Pethraj Shah Medical College attached with Guru Gobind Singh Hospital, a tertiary care teaching hospital, Jamnagar, Gujarat over a period of 6 months. For statistical analysis, ADR were analyzed by using Chi-square test. Results: Out of total 860 patients admitted, 830 were analyzed as they met the inclusion criteria. A total of 45 (5.42%) patients developed 47 ADR. Among them, 27 (3.25 %) (95% CI, 2.03%, 4.47%) patients due to ADR required hospital admission in medicine ward (ADR Ad), 18 (2.17%) (95% CI, 1.17%-3.17%) patients developed ADR while already hospitalized in medicine ward (ADR In). Most of the fatal and life-threatening reactions occurred due to chemotherapeutic agents. Majority of patients discontinued suspected drug and recovered from ADR. Conclusion: Fatal and life-threatening adverse reactions reported in the present as well as other studies underline the importance of such studies and need for creating awareness among health professionals about looking for and reporting such reactions.

Keywords: Adverse drug reaction, adverse drug reactions, cohort study


How to cite this article:
Vora MB, Trivedi HR, Shah BK, Tripathi C B. Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study. J Pharmacol Pharmacother 2011;2:21-5

How to cite this URL:
Vora MB, Trivedi HR, Shah BK, Tripathi C B. Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study. J Pharmacol Pharmacother [serial online] 2011 [cited 2019 Nov 12];2:21-5. Available from: http://www.jpharmacol.com/text.asp?2011/2/1/21/77102


   Introduction Top


Drugs are double edged weapons; they can save life but also can cause adverse drug reactions (ADR). ADR are a major cause of morbidity and mortality worldwide. [1],[2],[3],[4] According to World Health Organization (WHO) an ADR is defined as "A noxious, unintended and undesirable effect that occurs as a result of dose normally used in man for diagnosis, prophylaxis and treatment of disease or modification of physiological function." [5]

ADR in hospital patients can be divided into two broad categories: those that cause admission to hospital, and those that occur in in-patients after hospital admission. Approximately 5% (range 2%-20%) of reported hospitalizations are because of an ADR, [6] and at least one ADR has been reported to occur in 10%-20% of hospitalized patients. [7] They require expensive emergency room care. An ADR is associated with a significantly prolonged length of stay, increased economic burden, and almost twofold increased risk of death. [8] It is fourth to sixth leading cause of mortality in the United States of America. [3]

An ADR reporting program on an institutional basis can support the setting up of a sound pharmacovigilance system in the country. Furthermore, productive hospital-based ADR program can provide valuable information about potential problems in drug usage. [9] ADR occurring in hospital setting can be attributed to severity and complexity of disease process, use of multiple drugs, drug interactions, and possible negligence. [8] ADR could be monitored through active participation or through voluntary reporting system in hospital set up. The objective of this study were to find out incidence of ADR in patients of medicine wards and study various aspects of ADR, e.g., causality, mortality, drugs commonly causing ADR in internal medicine wards of Guru Gobind Singh Hospital, Jamnagar, a tertiary care hospital.


   Materials and Methods Top


This was a prospective observational cohort study conducted at the Department of medicine, Shri Meghji Pethraj Shah Medical College and associated Guru Gobind Singh hospital, Jamnagar, Gujarat (India). This study was conducted for period of 6 months in a cohort of hospital patients. All patient related information was collected as per case record form. Any untoward event was labeled as ADR only after discussing with the treating physician. In the case of any difference of opinion with respect to reaction, treating physician's opinion was considered as final. In case of doubt investigation was carried out with consent of physician to confirm ADR. No intervention was made in the treatment; observations, remarks, diagnosis, or management of the patient's disease. All treating physicians and patients were assured regarding confidentiality of the patient information. The patients meeting the following criteria were included in the study:

  1. All patients of either sex and age >12 years admitted in internal medicine wards.
  2. Patients referred to higher center, or discharged against medical advice but in whom the outcome of ADR was known.
  3. Patients transferred from Intensive Care Unit and Intensive Coronary Care Unit to internal medicine wards.


Patients referred to higher center, or discharged against medical advice and in whom outcome of ADR was not known, patients transferred to some other department during his/her drug treatment and those directly admitted to Intensive Care Unit, dialysis unit, TB chest ward, isolation ward were not included in the study. An approximate sample size (n = 763) was calculated using a pilot study. [10] Patients were followed up till discharged.

Statistical analysis

Results are expressed in absolute number and percentages. Comparisons between incidences of ADR in different age groups were performed using Chi-square test. P < 0.05 is considered significant.


   Results Top


A total of 860 patients were admitted in the internal medicine wards during study period and 30 patients were excluded as they did not fulfill the inclusion criteria. All patients included in the study were followed up daily. Drug therapy and any changes made in the same were recorded till the patient was discharged. Of the 830 patients, 45 had developed 47 ADR. Therefore, the incidence of ADR amounts to 5.42% in internal medicine wards. Maximum number of ADR (24 /45) occurred in age group 21-50 years [Table 1]. Total number of patients in this group was 421. The incidences of ADR in males and females were 3.37% and 2.05%, respectively [Table 2].
Table 1: Age groups of patients and adverse drug reaction (n = 830)

Click here to view
Table 2: Sex of patients and adverse drug reaction (n = 830)

Click here to view


The causality assessment (World Health Organization causality assessment criteria) of 47 ADR is depicted in [Figure 1]. Twenty eight (59.57%) ADR classified as ''Certain,'' 14 (29.79%) as ''Possible.'' Among 830 patients studied, 19 groups of drugs were found to cause various ADR. Among these, total 6 drugs from chemotherapeutic group of drugs produced 19 numbers of ADR. Chloroquine phosphate was the most common drug causing ADR [Figure 2]. It was found that 26 (3.13%) patients suffered ADR who received up to 3-5 numbers of drugs, and 16 numbers of patients having ADR received 2 drugs [Table 3]. As far as serious ADR are concerned (as per World Health Organization definition), 2 (4.25%) were fatal, 14 (29.79%) were life-threatening, and 30 (62.83%) required hospitalization (initial or prolonged) [Figure 3]. The management of ADR and outcome are given in tables [[Table 4] and [Table 5], respectively].
Figure 1: Causality of ADR and its occurrence rate

Click here to view
Figure 2: Drugs causing adverse drug reactions

Click here to view
Figure 3: Seriousness of adverse drug reactions.

Click here to view
Table 3: Total number of drugs administered and adverse drug reaction (n = 830)

Click here to view
Table 4: Management of adverse drug reaction (n = 47)

Click here to view
Table 5: Outcome for management of adverse drug reaction (n = 47)

Click here to view



   Discussion Top


The incidence of ADR in internal medicine wards in this study is higher than other published studies. [11] Sharma et al. reported an 4.67% incidence of ADR in a pharmacovigilance study as compared to 2.17% (95% CI, 1.17%-3.17%) observed in in-patients. The percentage of patients requiring admission was 3.1% which was slightly lower than that observed in our study (3.25%; 95% CI, 2.03%-4.47%). [12] Majority of the ADR occurred in the age group of 21-50 year (group 2, n = 24). However, maximum number of admissions occurred in this group of patients (n = 421) which needs to be kept in mind. This report thus slightly differs from other studies. [13],[14]

Males have greater risk of ADR (n = 28, 3.37%) than females (n = 17, 2.05%). However, this needs to be interpreted in the light of higher number of male admissions. There are various factors affecting the ADR incidence, e.g., age of patients, gender, number of drug exposure, length of hospital stay, genetic factors, ethnicity, dietary, and environmental factors, etc. The main factor affecting differences in ADR incidence could be attributed to inconsistent or contradictory methods among the individual studies. Another example of inconsistent methodology is problem that some investigators include error in administration of drug, overdose of drug for reporting ADR. [7]

In our study antimicrobial-induced ADR were 40.43% which is similar to that reported by Leape et al. [15] In these antimicrobial groups, chloroquine phosphate was the most commonly involved drug causing ADR. This suggests the need to increase the awareness with regard to prescription of chloroquine phosphate particularly in patients with suspected malaria. In this study, occurrence of serious ADR (5.42%) seems to be higher compared to that cited in previously published reports. [12] A wide spectrum of life-threatening ADR, including hypersensitivity reactions, acute muscle dystonia, and digoxin toxicity were noticed. It is well-established fact that as the number of drugs increases, the chances of developing ADR also increases. But in present study, patients on 3-5 drugs showed increased ADR but when drugs were more than 10 in number, there was no increase or decreased ADR in the patients.

So far as management regarding ADR is concerned most of the drugs that were thought to cause ADR were discontinued (n = 28, 59.57%) and the majority of patients fully recovered (n = 41, 87.23%) before discharge from internal medicine wards. Mortality due to ADR was 0.2% of the total admissions, higher than the previous study. [11] The two fatal reactions were observed in the study were related to streptomycin-induced nephrotic syndrome and docetaxel (anticancer drug)-induced immunosuppression. The present study clearly shows that when one looks for occurrence of ADR consciously, more patients with ADR can be picked up and identified having ADR whether physician induced or drug induced. There is a need to inform and educate the treating doctor about the importance of observing for ADR following drugs, recording them correctly and reporting to the concerned authority. This practice will prove to be valuable in making the drug therapy safe and rational. There were some limitations of our study, e.g., small sample size, short period of 6 month duration; and patients are only from general medicine wards.


   Conclusion Top


In conclusion of our study, occurrence of ADR was found in internal medicine wards to be higher, especially that of serious ADR, compared to that reported in previous studies. ADR in hospitalized patients of internal medicine wards were less than those encountered in the patients who got admitted because of ADR. As quite a few reactions happen to be life-threatening/fatal, it is necessary to establish some regular reporting program. This study is useful as a preliminary in initiating a culture of ADR reporting among the health care professionals in hospital.

 
   References Top

1.Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 1992;2:356-67.   Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Murphy BM, Frigo LC. Development implementation and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp Pharm 1993;28:1199-204,1240.  Back to cited text no. 2
[PUBMED]    
3.Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. J Am Med Assoc 1998;279:1200-5.  Back to cited text no. 3
    
4.Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. J Am Med Assoc 1997;277:301-6.  Back to cited text no. 4
    
5.International drug monitoring: The role of hospital. Geneva, Switzerland: World Health Organization; 1969 (Technical report series No. 425).  Back to cited text no. 5
    
6.Einarson TR. Drug related hospital admission. Ann Pharmacother 1993;27:832-40.  Back to cited text no. 6
[PUBMED]    
7.Brennan TA, Leape LL, Laird NM, Herbert L, Localio RA, Lawthers AG, et al. Incidence of adverse drug events and negligence in hospitalized patients: Results of Harvard Medical Practice study 1. N Engl J Med 1991;324:370-6.  Back to cited text no. 7
    
8.Classen DC, Pestonik SL, Evans RS, Lioyd JF, Burke JP. Adverse drug events in hospitalized patients-excess length of stay, extra cost and attributable mortality. J Am Med Assoc 1997;277:301-6.  Back to cited text no. 8
    
9.Rao PG, Archana B, Jose J. Implementation and results of an adverse drug reaction reporting programme at an Indian teaching hospital. Indian J Pharmacol 2006;38:293-4.  Back to cited text no. 9
  Medknow Journal  
10.Mahajan BK, editor. Methods in biostatistics. In: Measures of population and vital statistics. 6thed. New Delhi: Jaypee Brothers; 2003. p. 256-7.  Back to cited text no. 10
    
11.Gor AP, Desai SV. Adverse drug reactions in the inpatients of Medicine department of a rural tertiary care teaching hospital and influence of Pharmacovigilance in reporting adverse drug reaction. Indian J Pharmacol 2008; 40: 37-40.  Back to cited text no. 11
[PUBMED]  Medknow Journal  
12.Sharma H, Kaper P, Aqil M, Pillai KK, Imam F. A 4 month Pharmacovigilance study in the department of medicine of 150 bedded teaching hospital (Abstract) I. J Pharmacovigilance Drug Safety 2005;2:70.  Back to cited text no. 12
    
13.Egger T, Dormann H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, et al. Identification of adverse drug reactions in geriatric inpatients using a computerized drug database. Drugs Aging 2003;20:769-76.   Back to cited text no. 13
[PUBMED]  [FULLTEXT]  
14.Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991;39:1093-9.   Back to cited text no. 14
[PUBMED]    
15.Leape LL, Brennan TA, Laird N, Lawthers AG, Lacalio AR, Brarnes BA, et al. The nature of adverse drug events in hospitalized patients: Result of the Harvard medical practice study-II. N Engl J Med 1991;324:377-84.  Back to cited text no. 15
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5]


This article has been cited by
1 Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study
M. T. Angamo,L. Chalmers,C. M. Curtain,D. Yilma,L. Bereznicki
Journal of Clinical Pharmacy and Therapeutics. 2018;
[Pubmed] | [DOI]
2 An Evaluation of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting in Dental Practice
Zahra Talattof,Azita Azad
Pakistan Journal of Nutrition. 2015; 14(10): 712
[Pubmed] | [DOI]
3 Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey
Johannes P. Mouton,Ushma Mehta,Andy G. Parrish,Douglas P. K. Wilson,Annemie Stewart,Christine W. Njuguna,Nicole Kramer,Gary Maartens,Marc Blockman,Karen Cohen
British Journal of Clinical Pharmacology. 2015; 80(4): 818
[Pubmed] | [DOI]
4 Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay Ė a systematic review
Lateef Mohiuddin Khan
European Journal of Clinical Pharmacology. 2013;
[Pubmed] | [DOI]
5 Pharmacovigilance of the cutaneous drug reactions in outpatients of Dermatology department at a tertiary care hospital
Inbaraj, S.D. and Muniappan, M. and Muthiah, N.S. and Amutha, A. and Glory Josephine, I. and Rahman, F.
Journal of Clinical and Diagnostic Research. 2012; 6(10): 1688-1691
[Pubmed]
6 Incidence, severity and financial burden associated with suspected unexpected serious adverse reactions (Susars) that arise in clinical trials
Kamalraj, R. and Revathy, J. and Vijey Aanandhi, M. and Murugan, M. and Ramanakumar, K.P.V.
Asian Journal of Pharmaceutical and Clinical Research. 2012; 5(SUPPL. 3): 98-101
[Pubmed]
7 Adverse drug reactions related to admissions and hospital stays: A systematic review from 2000-2011 [Reacciones adversas a medicamentos relacionadas con ingresos y estancias hospitalarias: Revisión sistemática de 2000-2011]
Salas Rojas, S.G. and Pérez Morales, M.E. and Meléndez López, S.G. and Castro Pastrana, L.I.
Revista Mexicana de Ciencias Farmaceuticas. 2012; 43(3): 19-35
[Pubmed]
8 Intensive Pharmacovigilance in the internal medicine ward of the Regional Hospital No.1 of the Mexican Institute of Social Security in Tijuana, B.C. [Farmacovigilancia intensiva en el servicio de medicina interna del Hospital Regional No.1 del Instituto Mexicano del Seguro Social en Tijuana, B.C.]
Salas Rojas, S.G. and Pérez Morales, M.E. and Meléndez López, S.G.
Revista Mexicana de Ciencias Farmaceuticas. 2012; 43(4): 55-68
[Pubmed]
9 Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at saudi arabian teaching hospital
Khan Dr., L.M. and Al-Harthi, S.E. and Saadah, O.I. and Al-Amoudi, A.B. and Sulaiman, M.I. and Ibrahim, I.M.
Saudi Medical Journal. 2012; 33(8): 863-868
[Pubmed]
10 Incidence, severity and financial burden associated with adverse drug reactions in medicine inpatients
Raut, A. and Diwan, A. and Patel, C. and Patel, P. and Pawar, A.
Asian Journal of Pharmaceutical and Clinical Research. 2011; 4(SUPPL. 2): 107-111
[Pubmed]
11 Repeated prescription of known identified drugs with a history of drug allergy
Wiwanitkit, V.
Journal of Pharmacology and Pharmacotherapeutics. 2011; 2(2): 133-134
[Pubmed]
12 Knowledge and attitudes concerning pharmacogenomics among healthcare professionals
Dodson C
Personalized Medicine. 2011; 8(4): 421-428
[Pubmed] | [DOI]



 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Introduction
    Materials and Me...
    Results
    Discussion
    Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed3969    
    Printed200    
    Emailed3    
    PDF Downloaded785    
    Comments [Add]    
    Cited by others 12    

Recommend this journal